# FDA Inspection 1059394 - Egis Pharmaceuticals PLC - June 08, 2018

Source: https://www.keypedia.com/records/fda_inspections/egis-pharmaceuticals-plc/f0b4b7d5-152c-4632-ba78-6e026c5d5feb
Source feed: FDA_Inspections

> FDA Inspection 1059394 for Egis Pharmaceuticals PLC on June 08, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059394
- Company Name: Egis Pharmaceuticals PLC
- Inspection Date: 2018-06-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 854860 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/egis-pharmaceuticals-plc/766a7964-cd50-4aec-8a09-2135e17fff56)
- [FDA Inspection 707726 - 2011-01-28](https://www.keypedia.com/records/fda_inspections/egis-pharmaceuticals-plc/279ce6a9-ab1d-4fe5-a873-6bf33ac305bb)

Company: https://www.keypedia.com/companies/egis-pharmaceuticals-plc/1eb07e4e-6018-439c-b020-f723bd90f596

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c